Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adverse Events of Oncologic Immunotherapy and Their Management
Fedricker Diane Barber
Asia-Pacific Journal of Oncology Nursing (2019) Vol. 6, Iss. 3, pp. 212-226
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Immunotherapy: an alternative promising therapeutic approach against cancers
Sneh Lata Gupta, Srijani Basu, Vijay Soni, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 10, pp. 9903-9913
Open Access | Times Cited: 65
Photothermal Effect of Gold Nanoparticles as a Nanomedicine for Diagnosis and Therapeutics
P. P. Praveen Kumar, Dong-Kwon Lim
Pharmaceutics (2023) Vol. 15, Iss. 9, pp. 2349-2349
Open Access | Times Cited: 39
A new landscape in illness uncertainty: A systematic review and thematic synthesis of the experience of uncertainty in patients with advanced cancer receiving immunotherapy or targeted therapy
Tori Langmuir, Alanna K. Chu, Ghizlène Sehabi, et al.
Psycho-Oncology (2023) Vol. 32, Iss. 3, pp. 356-367
Closed Access | Times Cited: 23
Update in TIGIT Immune-Checkpoint Role in Cancer
Tiziana Annese, Roberto Tamma, Doménico Ribatti
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 32
Role of Immunotherapy in the Treatment of Cancer: A Systematic Review
Sia Pei Ling, Long Chiau Ming, Jagjit Singh Dhaliwal, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5205-5205
Open Access | Times Cited: 29
Multi-Faceted Role of Luteolin in Cancer Metastasis: EMT, Angiogenesis, ECM Degradation and Apoptosis
Maria Teresa Rocchetti, Francesco Bellanti, Mariia Zadorozhna, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8824-8824
Open Access | Times Cited: 22
Direct comparison of canine and human immune responses using transcriptomic and functional analyses
Lyndah Chow, William H. Wheat, Dominique Ramirez, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Intratumoral injection therapies for locally advanced pancreatic cancer: systematic review
Coen Ysbrand Willink, Sjoerd Franciscus Maria Jenniskens, Nienke Johanna Maria Klaassen, et al.
BJS Open (2023) Vol. 7, Iss. 3
Open Access | Times Cited: 12
Health-related quality of life and its influencing factors among lung cancer patients receiving immune checkpoint inhibitors: A cross-sectional study
Hong Wang, Dong Yan, Tiantian Fan, et al.
European Journal of Oncology Nursing (2024) Vol. 68, pp. 102507-102507
Closed Access | Times Cited: 4
Stability analysis and numerical simulations for interactions of tumor-immune system with drug delivery
Manisha Yadav, Paramjeet Singh
Chaos Solitons & Fractals (2025) Vol. 192, pp. 115971-115971
Closed Access
The Role of the Innate Immune System in Cancer Dormancy and Relapse
Noah M. Chernosky, Ilaria Tamagno
Cancers (2021) Vol. 13, Iss. 22, pp. 5621-5621
Open Access | Times Cited: 22
Biological Bases of Immune-Related Adverse Events and Potential Crosslinks With Immunogenic Effects of Radiation
Lilia Bardoscia, Nadia Pasinetti, Luca Triggiani, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 21
Adverse Renal Effects of Anticancer Immunotherapy: A Review
Maciej Borówka, Stanisław Łącki-Zynzeling, Michał Nicze, et al.
Cancers (2022) Vol. 14, Iss. 17, pp. 4086-4086
Open Access | Times Cited: 14
Nanotheranostic Strategies for Cancer Immunotherapy
Anh Hiep Nguyen, Sahana Kumar, Ashish Kulkarni
Small Methods (2022) Vol. 6, Iss. 12
Open Access | Times Cited: 14
Delayed hemorrhagic gastritis caused by immunotherapy in a patient With metastatic melanoma
Mohamed Elmasry, Brian Dong, Cristian D. Rios, et al.
The American Journal of the Medical Sciences (2022) Vol. 364, Iss. 3, pp. 343-346
Closed Access | Times Cited: 11
Efficacy of a Patient Education Session for Cancer Patients Receiving Immunotherapy
Stephanie Teixeira-Poit, Katelin Sawicki, Wendy O'Kelley, et al.
Seminars in Oncology Nursing (2023) Vol. 39, Iss. 4, pp. 151445-151445
Open Access | Times Cited: 6
Severe oral erosive lichenoid reaction to pembrolizumab therapy
Indraneel Bhattacharyya, Hardeep Chehal, César A. Migliorati
Oral Surgery Oral Medicine Oral Pathology and Oral Radiology (2020) Vol. 130, Iss. 5, pp. e301-e307
Closed Access | Times Cited: 13
Why Don’t the Mutant Cells That Evade DNA Repair Cause Cancer More Frequently? Importance of the Innate Immune System in the Tumor Microenvironment
Shubhasmita Mohapatra, Jared Cafiero, Khosrow Kashfi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 5026-5026
Open Access | Times Cited: 4
The Role of Nurses in the Management of Adverse Events in Patients Receiving First-Line Axitinib Plus Immuno-Oncology Agents for Advanced Renal Cell Carcinoma
Sara Parreira, Kathleen H. Burns, Nancy P. Moldawer, et al.
Seminars in Oncology Nursing (2023) Vol. 40, Iss. 1, pp. 151545-151545
Open Access | Times Cited: 4
Unlocking the Potential of Gold as Nanomedicine in Cancer Immunotherapy
P. P. Praveen Kumar, Maggie Lee, Taeho Kim
Journal of Nanotheranostics (2024) Vol. 5, Iss. 2, pp. 29-59
Open Access | Times Cited: 1
Comparison of EQ-5D-3L with QLU-C10D in Metastatic Melanoma Using Cost-Utility Analysis
Hansoo Kim, G. T. Cook, Stephen Goodall, et al.
PharmacoEconomics - Open (2021) Vol. 5, Iss. 3, pp. 459-467
Open Access | Times Cited: 8
The Prognostic and Predictive Value of Human Gastrointestinal Microbiome and Exosomal mRNA Expression of PD-L1 and IFNγ for Immune Checkpoint Inhibitors Response in Metastatic Melanoma Patients: PROTOCOL TRIAL
Ana Erman, M Ignjatović, Katja Leskovšek, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 2016-2016
Open Access | Times Cited: 3
Applying Artificial Intelligence Prediction Tools for Advancing Precision Oncology in Immunotherapy: Future Perspectives in Personalized Care
Botle Precious Damane, Zilungile L. Mkhize‐Kwitshana, Mahlatse Cordelia Kgokolo, et al.
(2023), pp. 239-258
Closed Access | Times Cited: 2
Adverse Renal Effects of Anticancer Immunotherapy: A Review
Maciej Borówka, Stanisław Łącki-Zynzeling, Michał Nicze, et al.
(2022)
Open Access | Times Cited: 3
Onco-Primary Care of Patients Receiving Immune Checkpoint Inhibitors
Christopher Hoimes, Suzanne McGettigan, Lee Schwartzberg
The American Journal of Medicine (2024) Vol. 137, Iss. 12, pp. 1200-1209
Open Access
Page 1 - Next Page

Scroll to top